SCHEMBL27314723

SCHEMBL27314723

O=c1c(Br)c(Cl)nc2ccc(Cl)cn12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.41
▸ SLC2A1 P11166 4/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ HTT P42858 1/20 0.38
▸ FADS1 O60427 1/20 0.38
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2825625 0.83 GAA (0.50) PARP1KMT2AALDH1A1POLBGAA
SCHEMBL21772779 0.81 FADS1 (0.40) PARP1SLC2A1MEN1KMT2AALDH1A1
SCHEMBL23414973 0.80 FADS1 (0.52) PARP1SLC2A1MEN1KMT2AALDH1A1
SCHEMBL21772792 0.80 ALDH1A1 (0.41) PARP1SLC2A1MEN1KMT2AALDH1A1
SCHEMBL23456478 0.80 FADS1 (0.41) PARP1SLC2A1MEN1KMT2AALDH1A1
SCHEMBL29955989 0.77 MAPT (0.63) PARP1MEN1KMT2AALDH1A1POLB
SCHEMBL5131549 0.76 KDM4E (0.62) MEN1KMT2AALDH1A1POLBGAA
SCHEMBL3958536 0.75 PABPC1 (0.46) ALDH1A1POLBGAAFADS1PABPC1
SCHEMBL9203119 0.73 PABPC1 (0.43) PARP1ALDH1A1POLBGAAGABRA2
SCHEMBL21772731 0.72 ALDH1A1 (0.41) ALDH1A1POLBGAAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543879-A1 PROTACS FOR TARGETED DEGRADATION OF KAT2A AND KAT2B FOR THE TREATMENT OF CANCER University College Cardiff Consultants Limited (GB) 2025-04-30 — — EP disclosed
WO-2024003533-A1 PROTACS FOR TARGETED DEGRADATION OF KAT2A AND KAT2B FOR THE TREATMENT OF CANCER UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2024-01-04 — — WO disclosed
WO-2024003533-A1 PROTACS FOR TARGETED DEGRADATION OF KAT2A AND KAT2B FOR THE TREATMENT OF CANCER UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2024-01-04 — — WO disclosed
Send feedback